One Ascent Financial Services LLC Biogen Inc. Transaction History

One Ascent Financial Services LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $269,123 - $350,966	-951 Closed	0 $0
Q1 2021 Apr 27, 2021	SELL	$242.95 - $284.63 $228,858 - $268,121	-942 Reduced 49.76%	951 $266,000
Q4 2020 Feb 08, 2021	SELL	$236.26 - $355.63 $526,151 - $791,988	-2,227 Reduced 54.05%	1,893 $464,000
Q4 2020 Jan 13, 2021	BUY	$236.26 - $355.63 $588,759 - $886,229	2,492 Added 153.07%	4,120 $1.01 Million
Q3 2020 Nov 02, 2020	SELL	$264.77 - $305.71 $163,363 - $188,623	-617 Reduced 27.48%	1,628 $462,000
Q2 2020 Jul 21, 2020	BUY	$258.66 - $342.55 $36,471 - $48,299	141 Added 6.7%	2,245 $601,000
Q1 2020 Apr 14, 2020	SELL	$268.85 - $341.04 $260,246 - $330,126	-968 Reduced 31.51%	2,104 $666,000
Q4 2019 Feb 11, 2020	BUY	$220.06 - $304.07 $676,024 - $934,103	3,072 New	3,072 $912,000
Q3 2019 Nov 15, 2019	SELL	$217.44 - $243.88 $720,378 - $807,974	-3,313 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$219.29 - $241.72 $726,507 - $800,818	3,313 New	3,313 $775,000

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of One Ascent Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on One Ascent Financial Services LLC with notifications on news.